Cargando…
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
INTRODUCTION: Malignant pleural mesothelioma (MPM) is a lethal cancer for which early-stage diagnosis remains a major challenge. Volatile organic compounds (VOCs) in breath proved to be potential biomarkers for MPM diagnosis, but translational studies are needed to elucidate which VOCs originate fro...
Autores principales: | Janssens, Eline, Mol, Zoë, Vandermeersch, Lore, Lagniau, Sabrina, Vermaelen, Karim Y., van Meerbeeck, Jan P., Walgraeve, Christophe, Marcq, Elly, Lamote, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120820/ https://www.ncbi.nlm.nih.gov/pubmed/35600344 http://dx.doi.org/10.3389/fonc.2022.851785 |
Ejemplares similares
-
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma
por: Janssens, Eline, et al.
Publicado: (2022) -
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
por: Lagniau, Sabrina, et al.
Publicado: (2017) -
Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study
por: Lamote, Kevin, et al.
Publicado: (2017) -
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis
por: Schillebeeckx, Eline, et al.
Publicado: (2021) -
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma
por: Rovers, Sophie, et al.
Publicado: (2022)